The ESMO Colloquia are innovative new sessions within the Congress programme that bring together top experts to discuss evolving areas of interest to the oncology community.
The Colloquia are organised by ESMO and supported by the industry in a unique collaboration making them the perfect complement to the scientific and education programme of the Congress.
Wednesday, 10 April 2019
ESMO Colloquium - How to Best Use Immune Checkpoint Inhibitors in NSCLC: Single Agents or Combined With Chemotherapy?
Room A, 11:45 – 13:15
View the ESMO Colloquium details
- Review the optimal immunotherapy options for NSCLC in first line
- Discuss the rationale for combining Immune Check Points (ICPs) among themselves or with cytotoxic drugs
- Evaluate the role of anti-angiogenics in combination with Chemotherapy and ICPs treatment
This educational activity is provided by ESMO and supported by Lilly in collaboration with MSD.